Daniel Horber
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Nanoparticle-Based Drug Delivery 9
- Oncology 11
- Colorectal Cancer Surgical Treatments 4
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- Herbert N. Schott (11 shared papers)Reto Albert Schwendener (8 shared papers)R.A. Schwendener (5 shared papers)Dieter Koeberle (7 shared papers)Peter von Ballmoos (3 shared papers)Piercarlo Saletti (3 shared papers)Cornelia Ottiger (2 shared papers)Karin Ribi (3 shared papers)
- Journals
- British Journal of Cancer (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Journal of Liposome Research (2 papers)Annals of Oncology (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- SwitzerlandGermanyHungary
In The Last Decade
Daniel Horber
23 papers receiving 390 citations
Peers
Comparison fields: 5 of 34
- Biomaterials 144
- Hepatology 82
- Oncology 92
- Pharmaceutical Science 18
- Toxicology 11
Countries citing papers authored by Daniel Horber
This map shows the geographic impact of Daniel Horber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Horber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Horber more than expected).
Fields of papers citing papers by Daniel Horber
This network shows the impact of papers produced by Daniel Horber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Horber. The network helps show where Daniel Horber may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Horber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 112 | |
| 2 | 2018 | 25 | |
| 3 | 1995 | 24 | |
| 4 | 1995 | 20 | |
| 5 | 1997 | 19 | |
| 6 | 1996 | 18 | |
| 7 | 2000 | 18 | |
| 8 | 1995 | 17 | |
| 9 | 2013 | 17 | |
| 10 | 1995 | 16 | |
| 11 | 2017 | 15 | |
| 12 | 1994 | 14 | |
| 13 | 1995 | 14 | |
| 14 | 1994 | 12 | |
| 15 | 1995 | 12 | |
| 16 | 2020 | 11 | |
| 17 | 1994 | 10 | |
| 18 | 2025 | 9 | |
| 19 | 1995 | 7 | |
| 20 | 2024 | 6 |
About Daniel Horber
Daniel Horber is a scholar working on Biomaterials, Oncology, Toxicology, Molecular Biology and Hepatology, having authored 24 papers that have together received 402 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Cancer therapeutics and mechanisms (6 papers), Bioactive Compounds and Antitumor Agents (4 papers), Colorectal Cancer Surgical Treatments (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Inflammatory mediators and NSAID effects (2 papers), Acute Myeloid Leukemia Research (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Biomaterials (144 citations), Hepatology (82 citations), Oncology (92 citations), Pharmaceutical Science (18 citations) and Toxicology (11 citations). Daniel Horber has collaborated with scholars based in Switzerland, Germany and Hungary. Frequent co-authors include Herbert N. Schott, Reto Albert Schwendener, R.A. Schwendener, Dieter Koeberle, Peter von Ballmoos, Piercarlo Saletti, Cornelia Ottiger, Karin Ribi, Gyorgy Bodoky and Michael Montemurro. Their work appears in journals such as British Journal of Cancer, Journal of Cancer Research and Clinical Oncology, Journal of Liposome Research, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.